Oura’s $625 million Counsel Health deal targets physician access

By Priya Raman

Oura agreed to acquire medical AI chatbot startup Counsel Health for $625 million, announcing the deal with its quarterly earnings. Oura expects the transaction to close before the end of the year.

The purchase follows the company’s addition of Counsel’s chatbot to the Oura app earlier this year, so the interface already exists; the acquisition brings the clinical AI and physician network under Oura ownership.

What changes inside the app?

Counsel Health calls itself an “AI-native primary care company.” Its chatbot uses health data reported by users’ wearables to generate AI responses and insights, then lets a user continue into a conversation with an in-house physician.

A doctor visit could start with a readout of Oura ring data. In interface terms, the pattern moves from wearable input to AI-generated guidance to human care without requiring a separate app. Think of a triage desk attached to a wearable feed, not a replacement for one.

What is Oura buying?

Tom Hale said in an interview with Bloomberg that the acquisition is part of a plan to “connect wearables, clinical AI, and access to doctors” based on insights from biometric data. The system is intended to answer questions and monitor ongoing conditions.

That is a service claim, not a demonstrated clinical result. Oura’s announcement gives no figures for response accuracy, physician wait time, consultations completed, or changes in health outcomes. The announcement also says nothing about how the chatbot distinguishes general guidance from medical advice, when a physician reviews an answer, or how users control the underlying data.

Which care paths does the plan target?\n

Oura and Counsel describe three areas:

• Preventative care.
• Acute care for episodic health concerns.
• Specialty and chronic care, including reproductive and cardiometabolic health.

The scope runs from prevention through sudden problems and long-term specialist issues. That breadth raises a practical interface requirement: users need to know when an automated answer ends and clinician care begins, and which data informed the answer. The announcement describes a doctor connection, but not those distinctions.

How large is the human layer?

Counsel Health CEO Muthu Alagappan told Bloomberg that the on-demand physician network is “made up of about 50 people” and that Counsel plans to expand it. The announcement provides no hiring timetable, coverage schedule, or specialty mix, so the planned scale remains open-ended rather than measurable.

All 70 Counsel employees will join Oura as part of the deal. Alagappan will become Oura’s chief clinical AI officer, putting the incoming executive in charge of the clinical AI strategy that links ring data to physician access.

Will the platform remain available outside Oura?

Yes, according to Oura. Counsel will continue offering its medical AI platform beyond Oura’s user base through new and existing enterprise partners, including health plans, health systems, consumer health organizations, and employers.

That keeps Counsel’s platform available outside Oura’s consumer base. It also leaves open whether enterprise users receive the same in-app physician handoff, whether service and data terms differ, and what happens to non-Oura users. The announcement does not answer those questions.

What would make this more than an AI handoff?

Oura would need to publish measures for time to physician, rate of AI-to-human escalation, accuracy across the three care areas, and health outcomes. Until then, the $625 million transaction buys an ambitious workflow, not proof of clinical benefit.

The concrete forward path is visible, though: wearable data enters the chatbot, an AI response appears in the app, and an in-house physician can continue the exchange. If Oura makes each handoff and its result measurable, the acquisition could mature from a feature into a care service. Without that evidence, it remains a well-specified interface experiment.